Mass., Apr 05, 2011 (BUSINESS WIRE) -- BioTime, Inc. /quotes/comstock/14*!btx/quotes/nls/btx (BTX 7.54, -0.01, -0.13%) , a biotechnology company that develops and markets products in the field of stem cells and regenerative medicine, today announced it...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to BioTime and XenneX Form LifeMap Sciences, Inc. to Create Roadmap for Regenerative Medicine
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account